The shift from being an ancillary tool to becoming the main location of work means legacy security solutions, such as ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

There isn’t a consistent threat model for extension marketplaces yet, McCarthy said, making it difficult for any platform to ...

Renalys Pharma reaches Japan PMDA agreement on phase III trials of sparsentan for FSGS and Alport syndrome: Tokyo, Japan Monday, October 20, 2025, 18:00 Hrs [IST] Renalys Pharma, ...

Built to defend enterprise networks, network edge security devices are becoming liabilities, with an alarming rise in ...

ClickFix, FileFix, fake CAPTCHA — whatever you call it, attacks where users interact with malicious scripts in their web ...

Novo Nordisk's Rybelsus gets US FDA approval for CV risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event ...

Genians, a company specializing in cybersecurity, announced on the 20th that it has successfully concluded its participation ...

AWS/CTIB Cybersecurity Startup Accelerator to support cybersecurity startups, positioning UAE as a leading global hub for ...

In the shadowy corridors of global cyber espionage, a new and increasingly aggressive actor has emerged, one that is ...

Sanofi's Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program If approved, Tzield would be the first disease-mo ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...